Cover Image
市場調查報告書

細菌性陰道炎:全球臨床實驗檢討

Bacterial Vaginosis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 244195
出版日期 內容資訊 英文 77 Pages
訂單完成後即時交付
價格
Back to Top
細菌性陰道炎:全球臨床實驗檢討 Bacterial Vaginosis Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月17日 內容資訊: 英文 77 Pages
簡介

本報告提供全球細菌性陰道炎治療藥臨床實驗相關調查,提供您各地區的臨床試驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗資料、中斷(暫時停止,廢止,截止)的實驗清單等。

簡介

  • 細菌性陰道炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 前五名國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量

Phase別臨床實驗數量: G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗者人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 細菌性陰道炎 治療藥

有潛力的藥劑

  • 最新臨床實驗新聞

臨床實驗簡介

  • 有代表性的企業臨床實驗概要
    • Starpharma Holdings Limited
    • Symbiomix Therapeutics, LLC
    • Merck & Co., Inc.
    • Ferring International Center S.A.
    • AmVac AG
    • Osel Inc.
    • Mission Pharmacal Company
    • Actavis plc
    • Arun Pharmaceuticals Limited
    • Alfa Wassermann S.p.A
  • 有代表性的研究機關/醫院臨床實驗概要
    • University of Alabama at Birmingham
    • University of Pittsburgh
    • Shiraz University of Medical Sciences
    • Lawson Health Research Institute
    • Centers for Disease Control and Prevention
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • Mount Sinai Hospital
    • The National Institute of Allergy and Infectious Diseases
    • Ahvaz Jundishapur University of Medical Sciences

5大臨床實驗簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2422CTIDB

GlobalData's clinical trial report, "Bacterial Vaginosis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Vaginosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Vaginosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial Vaginosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Bacterial Vaginosis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Bacterial Vaginosis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Bacterial Vaginosis Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Bacterial Vaginosis
    • Sep 09, 2014: Symbiomix Therapeutics Makes First Corporate Announcement: Completion of Enrollment in a Phase 2 Clinical Trial of SYM-1219 for Bacterial Vaginosis
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Starpharma Holdings Limited
      • Clinical Trial Overview of Starpharma Holdings Limited
      • Symbiomix Therapeutics, LLC
      • Clinical Trial Overview of Symbiomix Therapeutics, LLC
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Ferring International Center S.A.
      • Clinical Trial Overview of Ferring International Center S.A.
      • AmVac AG
      • Clinical Trial Overview of AmVac AG
      • Osel Inc.
      • Clinical Trial Overview of Osel Inc.
      • Mission Pharmacal Company
      • Clinical Trial Overview of Mission Pharmacal Company
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • Arun Pharmaceuticals Limited
      • Clinical Trial Overview of Arun Pharmaceuticals Limited
      • Alfa Wassermann S.p.A
      • Clinical Trial Overview of Alfa Wassermann S.p.A
    • Clinical Trial Overview of Top Institutes / Government
      • University of Alabama at Birmingham
      • Clinical Trial Overview of University of Alabama at Birmingham
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Shiraz University of Medical Sciences
      • Clinical Trial Overview of Shiraz University of Medical Sciences
      • Lawson Health Research Institute
      • Clinical Trial Overview of Lawson Health Research Institute
      • Centers for Disease Control and Prevention
      • Clinical Trial Overview of Centers for Disease Control and Prevention
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Mount Sinai Hospital
      • Clinical Trial Overview of Mount Sinai Hospital
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Ahvaz Jundishapur University of Medical Sciences
      • Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Starpharma Holdings Limited, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Symbiomix Therapeutics, LLC, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AmVac AG, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Osel Inc., 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mission Pharmacal Company, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Arun Pharmaceuticals Limited, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfa Wassermann S.p.A, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai Hospital, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014*

List of Figures

List of Figures

  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top